These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 30290700)

  • 1. Update on: proteome analysis in thyroid pathology - part II: overview of technical and clinical enhancement of proteomic investigation of the thyroid lesions.
    Piga I; Casano S; Smith A; Tettamanti S; Leni D; Capitoli G; Pincelli AI; Scardilli M; Galimberti S; Magni F; Pagni F
    Expert Rev Proteomics; 2018 Nov; 15(11):937-948. PubMed ID: 30290700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteomics for the diagnosis of thyroid lesions: preliminary report.
    Pagni F; Mainini V; Garancini M; Bono F; Vanzati A; Giardini V; Scardilli M; Goffredo P; Smith AJ; Galli M; De Sio G; Magni F
    Cytopathology; 2015 Oct; 26(5):318-24. PubMed ID: 25040579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteomics in thyroid cytopathology: Relevance of MALDI-imaging in distinguishing malignant from benign lesions.
    Pagni F; De Sio G; Garancini M; Scardilli M; Chinello C; Smith AJ; Bono F; Leni D; Magni F
    Proteomics; 2016 Jun; 16(11-12):1775-84. PubMed ID: 27029406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular signatures of medullary thyroid carcinoma by matrix-assisted laser desorption/ionisation mass spectrometry imaging.
    Smith A; Galli M; Piga I; Denti V; Stella M; Chinello C; Fusco N; Leni D; Manzoni M; Roversi G; Garancini M; Pincelli AI; Cimino V; Capitoli G; Magni F; Pagni F
    J Proteomics; 2019 Jan; 191():114-123. PubMed ID: 29581064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MALDI-MSI Analysis of Cytological Smears: The Study of Thyroid Cancer.
    Mosele N; Smith A; Galli M; Pagni F; Magni F
    Methods Mol Biol; 2017; 1618():37-47. PubMed ID: 28523498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Feasibility Study for the MALDI-MSI Analysis of Thyroid Fine Needle Aspiration Biopsies: Evaluating the Morphological and Proteomic Stability Over Time.
    Piga I; Capitoli G; Tettamanti S; Denti V; Smith A; Chinello C; Stella M; Leni D; Garancini M; Galimberti S; Magni F; Pagni F
    Proteomics Clin Appl; 2019 Jan; 13(1):e1700170. PubMed ID: 30411853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytological Cytospin Preparation for the Spatial Proteomics Analysis of Thyroid Nodules Using MALDI-MSI.
    Piga I; Pagni F; Magni F; Smith A
    Methods Mol Biol; 2023; 2688():95-105. PubMed ID: 37410287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ex vivo thyroid fine needle aspirations as an alternative for MALDI-MSI proteomic investigation: intra-patient comparison.
    Piga I; Capitoli G; Clerici F; Mahajneh A; Brambilla V; Smith A; Leni D; L'Imperio V; Galimberti S; Pagni F; Magni F
    Anal Bioanal Chem; 2021 Feb; 413(5):1259-1266. PubMed ID: 33277997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The management of haemoglobin interference for the MALDI-MSI proteomics analysis of thyroid fine needle aspiration biopsies.
    Piga I; Capitoli G; Denti V; Tettamanti S; Smith A; Stella M; Chinello C; Leni D; Garancini M; Galimberti S; Magni F; Pagni F
    Anal Bioanal Chem; 2019 Aug; 411(20):5007-5012. PubMed ID: 31147760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Classification of Thyroid Tumors Based on Mass Spectrometry Imaging of Tissue Microarrays; a Single-Pixel Approach.
    Kurczyk A; Gawin M; Chekan M; Wilk A; Łakomiec K; Mrukwa G; Frątczak K; Polanska J; Fujarewicz K; Pietrowska M; Widlak P
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32878024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of Hashimoto's thyroiditis on fine needle aspiration samples by MALDI-Imaging.
    Capitoli G; Piga I; Clerici F; Brambilla V; Mahajneh A; Leni D; Garancini M; Pincelli AI; L'Imperio V; Galimberti S; Magni F; Pagni F
    Biochim Biophys Acta Proteins Proteom; 2020 Nov; 1868(11):140481. PubMed ID: 32645440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular profiles of thyroid cancer subtypes: Classification based on features of tissue revealed by mass spectrometry imaging.
    Pietrowska M; Diehl HC; Mrukwa G; Kalinowska-Herok M; Gawin M; Chekan M; Elm J; Drazek G; Krawczyk A; Lange D; Meyer HE; Polanska J; Henkel C; Widlak P
    Biochim Biophys Acta Proteins Proteom; 2017 Jul; 1865(7):837-845. PubMed ID: 27760391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paving the path toward multi-omics approaches in the diagnostic challenges faced in thyroid pathology.
    Piga I; L'Imperio V; Capitoli G; Denti V; Smith A; Magni F; Pagni F
    Expert Rev Proteomics; 2023; 20(12):419-437. PubMed ID: 38000782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular trait of follicular-patterned thyroid neoplasms defined by MALDI-imaging.
    Piga I; Capitoli G; Clerici F; Brambilla V; Leni D; Scardilli M; Canini V; Cipriani N; Bono F; Valsecchi MG; Galimberti S; Magni F; Pagni F
    Biochim Biophys Acta Proteins Proteom; 2020 Nov; 1868(11):140511. PubMed ID: 32750549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The frequency of malignant disease in cytological group of suspected cancer (ultrasound-guided fine-needle aspiration biopsy of nonpalpable thyroid nodules)].
    Miseikyte-Kaubriene E; Ulys A; Trakymas M
    Medicina (Kaunas); 2008; 44(3):189-94. PubMed ID: 18413985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Results of fine needle aspiration biopsy, frozen section diagnosis and definite histological results in thyroid pathology. Report of 163 cases].
    Boutin P; Bozorg Grayeli A; Terrada C; Rondini-Gilli E; Mosnier I; Julien N; Bouccara D; Groussard O; Bok B; Sterkers O
    Rev Laryngol Otol Rhinol (Bord); 2003; 124(1):59-63. PubMed ID: 12934444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteomic profiles of thyroid tumors by mass spectrometry-imaging on tissue microarrays.
    Galli M; Pagni F; De Sio G; Smith A; Chinello C; Stella M; L'Imperio V; Manzoni M; Garancini M; Massimini D; Mosele N; Mauri G; Zoppis I; Magni F
    Biochim Biophys Acta Proteins Proteom; 2017 Jul; 1865(7):817-827. PubMed ID: 27939607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 'Indeterminate for malignancy' (Tir3/Thy3 in the Italian and British systems for classification) thyroid fine needle aspiration (FNA) cytology reporting: morphological criteria and clinical impact.
    Pagni F; Prada M; Goffredo P; Isimbaldi G; Crippa S; Di Bella C; Leone BE;
    Cytopathology; 2014 Jun; 25(3):170-6. PubMed ID: 23937572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical Subcellular Localization of Protein Biomarkers Distinguishes Benign from Malignant Thyroid Nodules: Potential for Fine-Needle Aspiration Biopsy Clinical Application.
    Ralhan R; Veyhl J; Chaker S; Assi J; Alyass A; Jeganathan A; Somasundaram RT; MacMillan C; Freeman J; Vescan AD; Witterick IJ; Walfish PG
    Thyroid; 2015 Nov; 25(11):1224-34. PubMed ID: 26131603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteomic identification of new biomarkers and application in thyroid cytology.
    Torres-Cabala C; Bibbo M; Panizo-Santos A; Barazi H; Krutzsch H; Roberts DD; Merino MJ
    Acta Cytol; 2006; 50(5):518-28. PubMed ID: 17017437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.